SARS-CoV-2 Seroprevalence after Third Wave of Infections, South Africa

Emerg Infect Dis. 2022 May;28(5):1055-1058. doi: 10.3201/eid2805.220278. Epub 2022 Mar 23.

Abstract

By November 2021, after the third wave of severe acute respiratory syndrome coronavirus 2 infections in South Africa, seroprevalence was 60% in a rural community and 70% in an urban community. High seroprevalence before the Omicron variant emerged may have contributed to reduced illness severity observed in the fourth wave.

Keywords: COVID-19; SARS-CoV-2; case-to-infection ratio; coronavirus disease; fatality-to-infection ratio; hospitalization-to-infection ratio; respiratory infections; seroprevalence; severe acute respiratory syndrome coronavirus 2; vaccine-preventable diseases; viruses; zoonoses.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • COVID-19* / epidemiology
  • Humans
  • SARS-CoV-2*
  • Seroepidemiologic Studies
  • South Africa / epidemiology

Supplementary concepts

  • SARS-CoV-2 variants